Allergan plc (AGN)


NYSE - NYSE Real Time Price. Currency in USD
239.43-3.84 (-1.58%)
As of 10:17 AM EDT. Market open.
People also watch:
BIIBCELGVRXGILDREGN
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open243.00
Prev Close243.27
Bid241.62 x 200
Ask241.97 x 200
Day's Range239.43 - 244.27
52wk Range195.50 - 322.68
1y Target EstN/A
Market Cap94.8B
P/E Ratio (ttm)22.80
Beta1.11
Volume953,468
Avg Vol (3m)3,123,604
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • Allergan, Humana, Biogen: Billionaires’ Favorite Healthcare Stocks For Q3
    Insider Monkey47 minutes ago

    Allergan, Humana, Biogen: Billionaires’ Favorite Healthcare Stocks For Q3

    The healthcare sector had one of its worst years in almost a decade last year when several big names from the space saw their stocks plunge dramatically. The beginning of 2016 was equally dismal for several healthcare stocks, but they have managed to recoup some of the losses they suffered last year over the past […]

  • Allergan Plc breached its 50 day moving average in a Bearish Manner : AGN-US : August 25, 2016
    Capital Cube2 hours ago

    Allergan Plc breached its 50 day moving average in a Bearish Manner : AGN-US : August 25, 2016

    Categories: ETFs Yahoo Finance Click here to see latest analysis *Disclaimer : This is as of previous day’s closing price. Technical Indicators Below is a quick look at 5 technical indicators for Allergan Plc. More studies are available on the Technical Chart. Indicator Signal Closing Price above/below 50 Day Moving Average Bearish Closing Price above/below 200 Day Moving Average ... Read more (Read more...)

  • Pfizer on buying spree with AstraZeneca antibiotics deal
    Associated Press17 hours ago

    Pfizer on buying spree with AstraZeneca antibiotics deal

    TRENTON, N.J. (AP) — Drugmaker Pfizer Inc. is continuing its shopping spree with its fourth acquisition since the April collapse of its planned $160 billion megadeal to buy rival Allergan PLC and move its headquarters, on paper, to Allergan's base in lower-tax Ireland.